Healthcare Early Movers: Opko Health Inc. (NYSE:OPK), Delcath Systems (NASDAQ:DCTH), Intercept Pharmaceuticals (NASDAQ:ICPT), Achillion Pharmaceuticals (NASDAQ:ACHN)

Opko Health (NYSE:OPK)’s CEO Phillip Md Et Al Frost bought 6,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 12th. The shares were purchased at an average price of $9.25 per share, with a total value of $55,500.00. Following the completion of the acquisition, the chief executive officer now directly owns 1,987,500 shares of the company’s stock, valued at approximately $18,384,375. The acquisition was disclosed in a document filed with the SEC. Opko Health Inc. (NYSE:OPK) stock opened today at $9.61 and is currently trading at $9.64. The stock showed a positive weekly performance of 3.67%.

Delcath Systems (NASDAQ:DCTH) released its earnings data on Wednesday. The company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.01, Analyst Ratings Network.com reports. The company had revenue of $0.30 million for the quarter, compared to the consensus estimate of $0.10 million. Delcath Systems, Inc. (NASDAQ:DCTH) stock opened at $0.33, in current trading session and currently is at $0.313, by loosing -0.48%.The 52 week range of $0.22-1.93. Company’s market capitalization is $47.17 million.

Citigroup Inc. raised their price objective on shares of Intercept Pharmaceuticals (NASDAQ:ICPT) from $600.00 to $700.00 in a research note issued on Friday, Stock Ratings Network reports. Citigroup Inc.’s price target would indicate a potential upside of 56.26% from the company’s current price. Intercept Pharmaceuticals Inc (NASDAQ:ICPT) stock is currently trading at $466.98 .The EPS of the stock is -5.09. Company’s market capitalization is $9.01 billion.

Achillion Pharmaceuticals (NASDAQ: ACHN) up 5%,  announced that two oral presentations were made at the 23rd Asian Pacific Association for the Study of the Liver (APASL) Conference 2014 in Brisbane, Australia. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock opened the session at $3.38, and now is at $3.46. The 52 week range of the ACHN stock remained $2.26-$9.14 and the day range was $3.37-$3.59.